-
Je něco špatně v tomto záznamu ?
Carborane-based carbonic anhydrase inhibitors: insight into CAII/CAIX specificity from a high-resolution crystal structure, modeling, and quantum chemical calculations
P. Mader, A. Pecina, P. Cígler, M. Lepšík, V. Šícha, P. Hobza, B. Grüner, J. Fanfrlík, J. Brynda, P. Řezáčová,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 2013
PubMed Central
od 2013
Europe PubMed Central
od 2013
ProQuest Central
od 2013
Open Access Digital Library
od 2001-01-01
Open Access Digital Library
od 2012-12-04
Open Access Digital Library
od 2013-01-01
CINAHL Plus with Full Text (EBSCOhost)
od 2013-01-01
Medline Complete (EBSCOhost)
od 2013-01-01
Health & Medicine (ProQuest)
od 2013
Wiley-Blackwell Open Access Titles
od 2001
ROAD: Directory of Open Access Scholarly Resources
od 2013
PubMed
25309911
DOI
10.1155/2014/389869
Knihovny.cz E-zdroje
- MeSH
- glycin chemie MeSH
- inhibitory karboanhydras chemie farmakologie MeSH
- karboanhydrasy chemie MeSH
- katalytická doména MeSH
- krystalografie rentgenová MeSH
- kvantová teorie * MeSH
- lidé MeSH
- molekulární modely * MeSH
- sloučeniny boru chemie farmakologie MeSH
- substrátová specifita účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Carborane-based compounds are promising lead structures for development of inhibitors of carbonic anhydrases (CAs). Here, we report structural and computational analysis applicable to structure-based design of carborane compounds with selectivity toward the cancer-specific CAIX isoenzyme. We determined the crystal structure of CAII in complex with 1-methylenesulfamide-1,2-dicarba-closo-dodecaborane at 1.0 Å resolution and used this structure to model the 1-methylenesulfamide-1,2-dicarba-closo-dodecaborane interactions with CAIX. A virtual glycine scan revealed the contributions of individual residues to the energy of binding of 1-methylenesulfamide-1,2-dicarba-closo-dodecaborane to CAII and CAIX, respectively.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15031792
- 003
- CZ-PrNML
- 005
- 20151008114113.0
- 007
- ta
- 008
- 151005s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1155/2014/389869 $2 doi
- 035 __
- $a (PubMed)25309911
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Mader, Pavel $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Vídeňská 1083, 140 00 Prague 4, Czech Republic ; Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada M5G 1L7.
- 245 10
- $a Carborane-based carbonic anhydrase inhibitors: insight into CAII/CAIX specificity from a high-resolution crystal structure, modeling, and quantum chemical calculations / $c P. Mader, A. Pecina, P. Cígler, M. Lepšík, V. Šícha, P. Hobza, B. Grüner, J. Fanfrlík, J. Brynda, P. Řezáčová,
- 520 9_
- $a Carborane-based compounds are promising lead structures for development of inhibitors of carbonic anhydrases (CAs). Here, we report structural and computational analysis applicable to structure-based design of carborane compounds with selectivity toward the cancer-specific CAIX isoenzyme. We determined the crystal structure of CAII in complex with 1-methylenesulfamide-1,2-dicarba-closo-dodecaborane at 1.0 Å resolution and used this structure to model the 1-methylenesulfamide-1,2-dicarba-closo-dodecaborane interactions with CAIX. A virtual glycine scan revealed the contributions of individual residues to the energy of binding of 1-methylenesulfamide-1,2-dicarba-closo-dodecaborane to CAII and CAIX, respectively.
- 650 _2
- $a sloučeniny boru $x chemie $x farmakologie $7 D001896
- 650 _2
- $a inhibitory karboanhydras $x chemie $x farmakologie $7 D002257
- 650 _2
- $a karboanhydrasy $x chemie $7 D002256
- 650 _2
- $a katalytická doména $7 D020134
- 650 _2
- $a krystalografie rentgenová $7 D018360
- 650 _2
- $a glycin $x chemie $7 D005998
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a molekulární modely $7 D008958
- 650 12
- $a kvantová teorie $7 D011789
- 650 _2
- $a substrátová specifita $x účinky léků $7 D013379
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pecina, Adam $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences and IOCB Research Center, Flemingovo nam. 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Cígler, Petr $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences and IOCB Research Center, Flemingovo nam. 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Lepšík, Martin $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences and IOCB Research Center, Flemingovo nam. 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Šícha, Václav $u Institute of Inorganic Chemistry, Academy of Sciences of the Czech Republic, v.v.i., Hlavní 1001, 250 68 Řež near Prague, Czech Republic.
- 700 1_
- $a Hobza, Pavel $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences and IOCB Research Center, Flemingovo nam. 2, 166 10 Prague 6, Czech Republic ; Regional Center of Advanced Technologies and Materials, Department of Physical Chemistry, Palacký University, 77146 Olomouc, Czech Republic.
- 700 1_
- $a Grüner, Bohumír $u Institute of Inorganic Chemistry, Academy of Sciences of the Czech Republic, v.v.i., Hlavní 1001, 250 68 Řež near Prague, Czech Republic.
- 700 1_
- $a Fanfrlík, Jindřich $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences and IOCB Research Center, Flemingovo nam. 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Brynda, Jiří $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Vídeňská 1083, 140 00 Prague 4, Czech Republic ; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences and IOCB Research Center, Flemingovo nam. 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Řezáčová, Pavlína $u Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Vídeňská 1083, 140 00 Prague 4, Czech Republic ; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences and IOCB Research Center, Flemingovo nam. 2, 166 10 Prague 6, Czech Republic.
- 773 0_
- $w MED00182164 $t BioMed research international $x 2314-6141 $g Roč. 2014, č. - (2014), s. 389869
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25309911 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20151005 $b ABA008
- 991 __
- $a 20151008114259 $b ABA008
- 999 __
- $a ok $b bmc $g 1092668 $s 914918
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 2014 $c - $d 389869 $e 20140918 $i 2314-6141 $m BioMed research international $n Biomed Res Int $x MED00182164
- LZP __
- $a Pubmed-20151005